As a pivotal hormone regulating red blood cell production, EPO has revolutionized the treatment of anemia in patients with ESRD, leading to improved hemoglobin levels and alleviation of symptoms such as fatigue and weakness [5]. This evidence concerns the gene EPO and anemia (phenotype).